Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inmune Bio (INMB) Interest & Investment Income (2019 - 2020)

Inmune Bio's Interest & Investment Income history spans 2 years, with the latest figure at $21854.0 for Q1 2020.

  • For Q1 2020, Interest & Investment Income rose 117.63% year-over-year to $21854.0; the TTM value through Mar 2020 reached $85456.0, changed N/A, while the annual FY2019 figure was $77688.0, N/A changed from the prior year.
  • Interest & Investment Income for Q1 2020 was $21854.0 at Inmune Bio, up from $17220.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $36340.0 in Q2 2019 and bottomed at $10042.0 in Q1 2019.